Daiwa Securities Group
AMLX icon

Daiwa Securities Group’s Amylyx Pharmaceuticals AMLX Stock Holding History

Daiwa Securities Group’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-266
Closed -$3K – 1195
2025
Q4 		$3K Hold
266
– – ﹤0.01% 1266
2025
Q3 		$4K Hold
266
– – ﹤0.01% 1216
2025
Q2 		$2K Hold
266
– – ﹤0.01% 1203
2025
Q1 		$1K Hold
266
– – ﹤0.01% 1209
2024
Q4 		$1K Hold
266
– – ﹤0.01% 1243
2024
Q3 		$1K Hold
266
– – ﹤0.01% 1241
2024
Q2 		$1K Hold
266
– – ﹤0.01% 1279
2024
Q1 		$1K Hold
266
– – ﹤0.01% 1287
2023
Q4 		$4K Hold
266
– – ﹤0.01% 1216
2023
Q3 		$5K Hold
266
– – ﹤0.01% 1152
2023
Q2 		$6K Hold
266
– – ﹤0.01% 1165
2023
Q1 		$8K Hold
266
– – ﹤0.01% 1120
2022
Q4 		$10K Buy
+266
New +$9.44K ﹤0.01% 1115

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Daiwa Securities Group's AMLX Position: Q1 2026 in Review

Daiwa Securities Group sold out of Amylyx Pharmaceuticals (AMLX) in Q1 2026, closing a stake of 266 shares — an estimated $3K sold.

Daiwa Securities Group first reported a position in AMLX in Q4 2022 and held it in 13 quarters. The position peaked at $10K in Q4 2022. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Daiwa Securities Group reported no remaining Amylyx Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 266 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $3K.
  • Daiwa Securities Group first reported a position in Amylyx Pharmaceuticals in Q4 2022 and held it in 13 quarters.
  • Daiwa Securities Group's Amylyx Pharmaceuticals position peaked at $10K in Q4 2022.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.